Validation of an enhanced International Prognostic Index (NCCN-IPI) in an Asian cohort of patients with diffuse large B cell lymphoma

被引：16

作者：

Huang, Cih-En ^{[1
,2
]}

Chen, Yi-Yang ^{[1
]}

Lu, Chang-Hsien ^{[1
]}

Chen, Pin-Tsung ^{[1
,2
]}

Lee, Kuan-Der ^{[1
,2
,3
]}

Chen, Chih-Cheng ^{[1
,2
,3
]}

机构：

[1] Chang Gung Mem Hosp, Dept Med, Div Hematol Oncol, Chiayi, Taiwan

[2] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan

[3] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan

来源：

ANNALS OF HEMATOLOGY | 2015年 / 94卷 / 06期

关键词：

CHOP;

D O I：

10.1007/s00277-014-2293-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1063 / 1065

页数：3

共 7 条

[1] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].

Coiffier, B ;

Lepage, E ;

Brière, J ;

Herbrecht, R ;

Tilly, H ;

Bouabdallah, R ;

Morel, P ;

Van den Neste, E ;

Salles, G ;

Gaulard, P ;

Reyes, F ;

Gisselbrecht, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242

[2]

Melchardt T, 2014, BR J HAEMATOL

[3] A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma [J].

Mian, M. ;

Marcheselli, L. ;

Rossi, A. ;

Visco, C. ;

Chiappella, A. ;

Volpetti, S. ;

Zaja, F. ;

Mondello, P. ;

Fiegl, M. ;

Billio, A. ;

Federico, M. ;

Luminari, S. ;

Rambaldi, A. ;

Cortelazzo, S. .

ANNALS OF ONCOLOGY, 2014, 25 (12) :2398-2404

[4] The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP [J].

Sehn, Laurie H. ;

Berry, Brian ;

Chhanabhai, Mukesh ;

Fitzgerald, Catherine ;

Gill, Karamjit ;

Hoskins, Paul ;

Klasa, Richard ;

Savage, Kerry J. ;

Shenkier, Tamara ;

Sutherland, Judy ;

Gascoyne, Randy D. ;

Connors, Joseph M. .

BLOOD, 2007, 109 (05) :1857-1861

[5] A PREDICTIVE MODEL FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA [J].

SHIPP, MA ;

HARRINGTON, DP ;

ANDERSON, JR ;

ARMITAGE, JO ;

BONADONNA, G ;

BRITTINGER, G ;

CABANILLAS, F ;

CANELLOS, GP ;

COIFFIER, B ;

CONNORS, JM ;

COWAN, RA ;

CROWTHER, D ;

DAHLBERG, S ;

ENGELHARD, M ;

FISHER, RI ;

GISSELBRECHT, C ;

HORNING, SJ ;

LEPAGE, E ;

LISTER, TA ;

MEERWALDT, JH ;

MONTSERRAT, E ;

NISSEN, NI ;

OKEN, MM ;

PETERSON, BA ;

TONDINI, C ;

VELASQUEZ, WA ;

YEAP, BY .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :987-994

[6] An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era [J].

Zhou, Zheng ;

Sehn, Laurie H. ;

Rademaker, Alfred W. ;

Gordon, Leo I. ;

LaCasce, Ann S. ;

Crosby-Thompson, Allison ;

Vanderplas, Ann ;

Zelenetz, Andrew D. ;

Abel, Gregory A. ;

Rodriguez, Maria A. ;

Nademanee, Auayporn ;

Kaminski, Mark S. ;

Czuczman, Myron S. ;

Millenson, Michael ;

Niland, Joyce ;

Gascoyne, Randy D. ;

Connors, Joseph M. ;

Friedberg, Jonathan W. ;

Winter, Jane N. .

BLOOD, 2014, 123 (06) :837-842

[7] Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+ B-Cell Lymphoma in the Rituximab Era [J].

Ziepert, Marita ;

Hasenclever, Dirk ;

Kuhnt, Evelyn ;

Glass, Bertram ;

Schmitz, Norbert ;

Pfreundschuh, Michael ;

Loeffler, Markus .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (14) :2373-2380

← 1 →